McGraneIR, LovelandJG, de LeonJ: Possible oxcarbazepine inductive effects on aripiprazole metabolism: A case report. J Pharm Pract, 31:361–363, 2018.
2.
PatornoE, BohnRL, WahlPM, AvornJ, PatrickAR, LiuJ, SchneeweissS: Anticonvulsant medications and the risk of suicide, attempted suicide, or violent death. JAMA, 303:1401–1409, 2010.
3.
RiceT, SimonH, BarcakD, MaiyruanH, ChanV, HassanY, TatumJ: Amantadine for the treatment of disruptive mood dysregulation disorder symptoms. J Child Adolesc Psychopharmacol, 29:642–646, 2019.
4.
SegeRD, Amaya-Jackson S; and the American Academy of Pediatrics Committee on Child Abuse andNeglect, Council on FosterCare, Adoption, and KinshipCare: Clinical considerations related to the behavioral manifestations of child maltreatment. Pediatrics, 139:e1–e13, 2017.
5.
van den AnkerJ, ReedMD, AllegaertK, KearnsGL: Developmental changes in pharmacokinetics and pharmacodynamics. J Clin Pharmacol 58(Suppl. 10):S10–S25, 2018.
